| 23rd Mar 2022 7:00 am |
RNS |
Fourth Quarter and Full Year Financial Results |
| 10th Mar 2022 7:00 am |
RNS |
MaxCyte, Names Cenk Sumen Chief Scientific Officer |
| 8th Mar 2022 2:29 pm |
RNS |
Holding(s) in Company |
| 3rd Mar 2022 9:45 am |
RNS |
Holding(s) in Company |
| 1st Mar 2022 7:00 am |
RNS |
Block Listing Return |
| 24th Feb 2022 1:00 pm |
RNS |
Notice of Results |
| 22nd Feb 2022 3:56 pm |
RNS |
Holding(s) in Company |
| 21st Feb 2022 7:00 am |
RNS |
Consolidation of Trading Lines |
| 14th Feb 2022 1:00 pm |
RNS |
Upcoming Investor Conferences |
| 14th Feb 2022 7:00 am |
RNS |
Inducement Grants Under Nasdaq Listing Rule |
| 1st Feb 2022 7:00 am |
RNS |
License with Intima Bioscience |
| 24th Jan 2022 7:30 am |
RNS |
Preliminary Unaudited Q4 & FY 2021 Revenue Results |
| 29th Dec 2021 3:30 pm |
RNS |
Holdings in Company |
| 1st Dec 2021 5:00 pm |
RNS |
Total Voting Rights |
| 23rd Nov 2021 7:32 am |
RNS |
Purchase of Common Stock |
| 17th Nov 2021 5:36 pm |
RNS |
Exercise of options and PDMR Dealing |
| 11th Nov 2021 7:00 am |
RNS |
MaxCyte Reports Third Quarter Financial Results |
| 3rd Nov 2021 1:00 pm |
RNS |
Appointment of Chairman of the Board |
| 29th Oct 2021 5:01 pm |
RNS |
Result of AGM |
| 28th Oct 2021 3:00 pm |
RNS |
License with Nkarta, Inc. |
| 26th Oct 2021 7:00 am |
RNS |
Notice of Results |
| 6th Oct 2021 7:00 am |
RNS |
Holdings in Company |
| 1st Oct 2021 3:49 pm |
RNS |
Notice of AGM and Change of Director |
| 1st Oct 2021 12:36 pm |
RNS |
Total Voting Rights |
| 17th Sep 2021 2:35 pm |
RNS |
MaxCyte Set to Join Russell 2000® Index |
| 14th Sep 2021 7:00 am |
RNS |
Half-year Report |
| 14th Sep 2021 7:00 am |
RNS |
Filing of Form 10-Q |
| 2nd Sep 2021 2:26 pm |
RNS |
Notice of Results |
| 10th Aug 2021 7:00 am |
RNS |
Grant of Options |
| 9th Aug 2021 7:00 am |
RNS |
License with Sana Biotechnology |
| 5th Aug 2021 4:05 pm |
RNS |
Amendments to Bylaws |
| 3rd Aug 2021 3:51 pm |
RNS |
Closing of Offering |
| 2nd Aug 2021 7:00 am |
RNS |
Full Exercise of Over-Allotment Option |
| 30th Jul 2021 4:43 pm |
RNS |
Second Price Monitoring Extn |
| 30th Jul 2021 4:36 pm |
RNS |
Price Monitoring Extension |
| 30th Jul 2021 7:00 am |
RNS |
Pricing of Offering and Approval to List on Nasdaq |
| 26th Jul 2021 11:14 am |
RNS |
Launch of Offering and Application to List |
| 19th Jul 2021 12:30 pm |
RNS |
Termination of DI facility and transition to CDI |
| 12th Jul 2021 7:00 am |
RNS |
S-1 Financial information & Directorate Change |
| 12th Jul 2021 7:00 am |
RNS |
Public Filing of Registration Statement with SEC |
